z-logo
open-access-imgOpen Access
Detection of germline deletions using real‐time quantitative polymerase chain reaction in Japanese patients with von Hippel–Lindau disease
Author(s) -
Hattori Keiko,
Teranishi Junichi,
Stolle Catherine,
Yoshida Minoru,
Kondo Keiichi,
Kishida Takeshi,
Kanno Hiroshi,
Baba Masaya,
Kubota Yoshinobu,
Yao Masahiro
Publication year - 2006
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/j.1349-7006.2006.00193.x
Subject(s) - germline , taqman , biology , genetics , germline mutation , exon , gene , microbiology and biotechnology , polymerase chain reaction , coding region , primer (cosmetics) , mutation , chemistry , organic chemistry
Germline mutations of the VHL gene are responsible for VHL. Approximately 70% of VHL families display small intragenic mutations detectable by sequencing, whereas partial‐ or whole‐gene deletions have been described in the majority of the remaining families. For such large deletions, complex genetic techniques other than sequencing might have to be used. In this study, we describe an RQ‐PCR assay with TaqMan fluorescent probes to detect germline VHL deletions. The RQ‐PCR primer/probe sets were designed for the three VHL coding exons as well as for the 5′ promoter and 3′ untranslated regions. The RQ‐PCR assay for 30 normal and 10 known VHL deletion control samples demonstrated high sensitivity and specificity. We then screened 29 individuals from 19 classical VHL families (16 type 1, 2 type 2A, and one type 2B) and one PHEO family, as well as four solitary suspected cases, none displaying any sequence changes, for VHL deletions by the RQ‐PCR assay. We detected germline deletions in 17 (89%) classical families including 15 type 1, one type 2A, and one type 2B. We also identified two mutation carriers and two non‐carriers in our family cohort. The one PHEO family and four solitary cases did not display any deletion patterns. These findings indicated that the TaqMan‐based RQ‐PCR assay is a simple and potent technique for the rapid, sensitive, and specific investigation of VHL genetic diagnoses that could be used profitably before more complex large‐deletion detection techniques. ( Cancer Sci 2006; 97 : 400 –405)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here